Five-year Recurrence-free Survival After Surgery Followed by Oral Chemotherapy for Gastric Cancer With Portal Vein Tumor Thrombosis

Anticancer Res. 2019 Apr;39(4):2233-2238. doi: 10.21873/anticanres.13339.

Abstract

Gastric cancer with portal vein tumor thrombosis (GC-PVTT) is a rare condition with a very poor prognosis. A 64-year-old man with GC-PVTT was admitted to our hospital. His carcinoembryonic antigen level was slightly elevated (17.4 ng/ml). Upper gastrointestinal endoscopy showed a type-2 gastric lesion (45 mm × 40 mm) in the gastric antrum. The PVTT originated from the main gastric tumor and continued to the superior mesenteric vein. Fluorodeoxyglucose-positron emission tomography showed high uptake both by the main tumor and PVTT. A distal gastrectomy with D2 lymphadenectomy was performed with simultaneous removal of the PVTT. Pathological examination showed a poorly differentiated adenocarcinoma with neuroendocrine differentiation. Adjuvant chemotherapy with S-1 was administered for 1 year. The patient survived for >5 years with no recurrence. Surgical gastrectomy and complete removal of the PVTT followed by S-1 chemotherapy could be a treatment option that offers improved long-term survival for patients with GC-PVTT.

Keywords: Gastric cancer; oral chemotherapy; portal vein tumor thrombosis; recurrence-free survival; surgery.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Disease-Free Survival
  • Drug Combinations
  • Gastrectomy*
  • Humans
  • Male
  • Middle Aged
  • Oxonic Acid / therapeutic use*
  • Portal Vein / pathology*
  • Stomach Neoplasms* / drug therapy
  • Stomach Neoplasms* / surgery
  • Tegafur / therapeutic use*
  • Venous Thrombosis* / drug therapy
  • Venous Thrombosis* / surgery

Substances

  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid